Cargando…
Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend
The natural history of chronic hepatitis B (CHB) is complex and may run through different immune phases that may overlap. In particulars, the immune-tolerant phase is the most interesting and not as well understood as we thought. The concept of true immune tolerance have been under challenged from i...
Autor principal: | Wong, Grace Lai-Hung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038942/ https://www.ncbi.nlm.nih.gov/pubmed/29353469 http://dx.doi.org/10.3350/cmh.2017.0068 |
Ejemplares similares
-
Unmet need in chronic hepatitis B management
por: Liang, Lilian Yan, et al.
Publicado: (2019) -
Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
por: Yip, Terry Cheuk-Fung, et al.
Publicado: (2021) -
Prediction of fibrosis progression in chronic viral hepatitis
por: Wong, Grace Lai-Hung
Publicado: (2014) -
The truth of the matter: will immune-tolerant chronic hepatitis B patients benefit from antiviral treatment?
por: Jeng, Wen-Juei, et al.
Publicado: (2023) -
KASL Clinical Practice Guidelines: Management of chronic hepatitis B
Publicado: (2012)